LocalGlobe has led a £3.7m seed round for quantum software developer Phasecraft, with participation from Episode1 and previous backers.
"Already in the past two years quantum hardware has surpassed expectations, achieving milestones that seemed decades away. By pioneering new advances in quantum software, Phasecraft can take quantum theory from research to reality, faster. With new funding and supporters, we can be part of building the foundations of the quantum computing industry, making useful applications available quicker than ever thought."
The funding round was backed by Parkwalk Advisors, The Angel CoFund, and UCL Technology Fund to support team expansion and product development.
"This funding will help us reach new retailers and further support our existing clients in addressing the challenges and opportunities of selling and advertising in a competitive and fast-growing marketplace. The application of machine learning, and the fusion of transactional data with media data, brings brands huge advantage in the Amazon environment, extracting maximum commercial value and sales performance. Our platform is at the forefront of unlocking this potential for international retailers."
— Victor Malachard, Co-Founder and Executive Chairman
The funding round was led by UCL Technology Fund, Parkwalk, and Innovate UK to support sensor development and clinical trials.
"Coronary heart disease is endemic worldwide but far too often the decision to implant a stent is based on sub-optimal information. Our technology addresses the ‘grey zone’ of patients where the requirement for a stent is currently difficult to determine. By using advanced optical sensing technology, we hope to significantly improve the accuracy of current treatments, saving healthcare costs and preventing unnecessary operations for patients that could be treated with medicines."
The Series A round was led by Syncona and included a £1m investment from the UCL Technology Fund.
"It’s really exciting to be in at the start of something that could potentially change the way things are done. By bringing together academia and commerce, Quell Therapeutics will be at the cutting edge of the research and development of this important field."
The seed round was led by Speedinvest to support the development of disinformation detection technology.
"While I was building my previous start-up I saw at first-hand how biased, polarising news articles were shared and artificially amplified by vast numbers of fake accounts. This gave the stories high levels of exposure and authenticity they wouldn’t have had on their own."
